InvestorsHub Logo
Followers 36
Posts 1736
Boards Moderated 0
Alias Born 05/13/2011

Re: None

Wednesday, 03/13/2019 1:18:29 PM

Wednesday, March 13, 2019 1:18:29 PM

Post# of 163
Title: A Probody Drug Conjugate Targeting CD166 (ALCAM) Enhances Preclinical Antitumor Activity of a Probody Therapeutic Targeting PD-1
Session Category: Immunology
Session Title: Combination Immunotherapies 2
Date and Time: Tuesday, April 2, 2019 8:00 a.m. - 12:00 p.m.
Location: Exhibit Hall B, Poster Section 23; Poster Board 12
Abstract Number: 3202

https://www.abstractsonline.com/pp8/#!/6812/presentation/2519
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTMX News